Propanc Biopharma (PPCB) Stock Statistics & Valuation Metrics

Propanc Biopharma has a market cap or net worth of $23.56M. The enterprise value is ―.

Propanc Biopharma has 12,806,747 shares outstanding. The number of shares has decreased by -2.65% in one year.

Propanc Biopharma’s return on equity (ROE) is -4.24 and return on invested capital (ROIC) is -378.01%.

The current PE Ratio of Propanc Biopharma is ―. Propanc Biopharma’s PEG ratio is 0.00282.

In the last 12 months, Propanc Biopharma had revenue of 0.00 and earned -58.92M in profits. Earnings per share was -14.85.

In the last 12 months, operating cash flow was -637.95K and capital expenditures 0.00, giving a free cash flow of -637.95K billion.

Propanc Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Propanc Biopharma upcoming earnings date is ―, ―.

Propanc Biopharma as a current ratio of 1.50, with Debt / Equity ratio of 6.89%

In the past 12 months, Propanc Biopharma has paid 0.00 in taxes.

Propanc Biopharma EV to EBITDA ratio is -0.31, with an EV/FCF ratio of -43.69.

Propanc Biopharma has $50.76K in cash and marketable securities with $1.25M in debt, giving a net cash position of -$1.20M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Propanc Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―